About Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd.
During the past decade, Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
2003-07-01
2012-12-01
Unknown status
6,000
Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
2009-10-01
2012-11-01
Completed
20
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
2016-09-09
2020-12-15
Completed
681
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
2017-03-24
2024-08-15
Active, not recruiting
1,239
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
2018-05-28
2026-12-04
Active, not recruiting
927
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd."
#1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd.
According to Clinical.Site data, the most researched conditions in "Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd." are
"Breast Cancer" (2 trials), "Glioblastoma" (1 trials), "Prostatic Neoplasms, Castration-Resistant" (1 trials) and "Urinary Tract Cancer" (1 trials). Many other conditions were trialed in "Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd." in a lesser frequency.
Clinical Trials Intervention Types at Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd.
Most popular intervention types in "Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd." are "Drug" (5 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Placebo" (2 trials), "5-Fluorouracil" (1 trials), "Bevacizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd.
The vast majority of trials in "Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd." are
4 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd.
Currently, there are NaN active trials in "Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd.".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Aalborg Universitetshospital, Klinik Kirurgi-Kræft, Onkologisk afd., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".